FEB 03, 2017 8:53 AM PST

Peripheral Helper T Cells Play Surprising Role in Rheumatoid Arthritis

WRITTEN BY: Kara Marker

A unique new type of T cells have apparently been “hiding in plain site,” say scientists invested in studying T cell involvement in rheumatoid arthritis, an autoimmune disorder.

Rheumatoid arthritis (RA) is the most common type of autoimmune arthritis, characterized by inflamed joints, low energy, appetite loss, and rheumatoid nodules, hard lumps that grow under the skin near the elbow and hands.

Source: Everyday Health

Like other autoimmune diseases, RA is a result of an immune response that goes awry; instead of recognizing human cells as harmless self cells, the immune system triggers an inflammatory response against them. However, other than understanding this general process, scientists are not completely sure what causes RA.

But now a new study provides some insight into the RA mystery, thanks to the discovery of a new type of T cell: “peripheral helper” T cells (Tph). These T cells are similar to follicular helper T cells (Tfh), but they have significant genetic and functional differences. For example, Tph cells are able to travel to RA-affected joint tissue where they interact locally with B cells. Tfh cells on the other hand, only induce B cell differentiation within the lymph nodes.

The new study, from scientists at the University of Birmingham, used mass cytometry to observe Tph cells after their migration to the synovial membrane in RA-affected joints and then global transcriptomics to differentiate Tph cells from Tfh cells. The synovial membrane consists of a layer of connective tissue that lines all joints and tendon sheaths.

The study researchers found that the journey Tph cells embark on into inflamed RA tissues is regulated by unique expression of chemokine receptors, chemical immune messengers employed for a variety of immune signaling duties. The researchers came to this conclusion after observing Tph cells inducing plasma differentiation in the lab.

“Our findings imply that Tph cells are uniquely poised to promote B-cell responses and antibody production within pathologically inflamed non-lymphoid tissues, and suggest a promising novel treatment target for autoimmune disease such as RA,” explained study co-author professor Christopher Buckley.

The current research surrounding Tph cells and RA has yet to demonstrate a clear cause and effect, but a connection between Tph cells and RA is undeniable. And perhaps, scientists think, maybe Tph cells are connected to other autoimmune diseases as well.

The recent study was published in the journal Nature.

Source: University of Birmingham, PubMed Health, American College of Rheumatology, MedlinePlus.gov

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 24, 2020
Drug Discovery & Development
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
AUG 24, 2020
FDA Grants Emergency Approval for Blood Plasma to Treat COVID-19
The US Food and Drug Agency (FDA) has given emergency approval for expanded use of antibody-rich blood plasma to help th ...
SEP 15, 2020
Immunology
Common Spice Relieves Eye Inflammation in Dogs, Human Studies to Follow
SEP 15, 2020
Common Spice Relieves Eye Inflammation in Dogs, Human Studies to Follow
A therapeutic made from turmeric has been shown to help reduce the effects of a painful inflammatory eye condition in do ...
SEP 17, 2020
Coronavirus
A Biomarker May Predict the Most Severe COVID-19 Cases
SEP 17, 2020
A Biomarker May Predict the Most Severe COVID-19 Cases
Researchers may have found a way to identify the COVID-19 patients that will need targeted therapies the most.
OCT 02, 2020
Immunology
Stop the Clot: A New Antibody Treatment for Thrombosis
OCT 02, 2020
Stop the Clot: A New Antibody Treatment for Thrombosis
Blood clotting helps stem the bleeding from a wound, suppressing blood loss and stopping pathogenic microorganisms from ...
NOV 12, 2020
Immunology
The Enzyme That Keeps Viruses In Stealth Mode
NOV 12, 2020
The Enzyme That Keeps Viruses In Stealth Mode
Some viral infections just don’t go away. The hepatitis C virus, for instance, can result in life-long chronic inf ...
NOV 26, 2020
Immunology
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
NOV 26, 2020
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
  There’s a new weapon in the battle against lung cancer metastases: red blood cells equipped with nanopartic ...
Loading Comments...